19 May 2013
Keywords: donepezil, filed, mexico, wyeth-ayerst, approval, market, alzheimer
Article | 20 March 1997
- Wyeth-Ayerst has filed for approval to market the Alzheimer's drugEranz (donepezil) in Mexico. The drug, developed by Eisai, has already ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.